Products of Vitamin D3 or 7-Dehydrocholesterol Metabolism by Cytochrome P450scc Show Anti-Leukemia Effects, Having Low or Absent Calcemic Activity
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cytochrome P450scc metabolizes vitamin D3 to 20-hydroxyvitamin D3 (20(OH)D3) and 20,23(OH)(2)D3, as well as 1-hydroxyvitamin D3 to 1alpha,20-dihydroxyvitamin D3 (1,20(OH)(2)D3). It also cleaves the side chain of 7-dehydrocholesterol producing 7-dehydropregnenolone (7DHP), which can be transformed to 20(OH)7DHP. UVB induces transformation of the steroidal 5,7-dienes to pregnacalciferol (pD) and a lumisterol-like compounds (pL). METHODS AND FINDINGS: To define the biological significance of these P450scc-initiated pathways, we tested the effects of their 5,7-diene precursors and secosteroidal products on leukemia cell differentiation and proliferation in comparison to 1alpha,25-dihydroxyvitamin D3 (1,25(OH)(2)D3). These secosteroids inhibited proliferation and induced erythroid differentiation of K562 human chronic myeloid and MEL mouse leukemia cells with 20(OH)D3 and 20,23(OH)(2)D3 being either equipotent or slightly less potent than 1,25(OH)(2)D3, while 1,20(OH)(2)D3, pD and pL compounds were slightly or moderately less potent. The compounds also inhibited proliferation and induced monocytic differentiation of HL-60 promyelocytic and U937 promonocytic human leukemia cells. Among them 1,25(OH)(2)D3 was the most potent, 20(OH)D3, 20,23(OH)(2)D3 and 1,20(OH)(2)D3 were less active, and pD and pL compounds were the least potent. Since it had been previously proven that secosteroids without the side chain (pD) have no effect on systemic calcium levels we performed additional testing in rats and found that 20(OH)D3 had no calcemic activity at concentration as high as 1 microg/kg, whereas, 1,20(OH)(2)D3 was slightly to moderately calcemic and 1,25(OH)(2)D3 had strong calcemic activity. CONCLUSIONS: We identified novel secosteroids that are excellent candidates for anti-leukemia therapy with 20(OH)D3 deserving special attention because of its relatively high potency and lack of calcemic activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It also shows anti-cancer and anti-tumor activities that are dependent on the cell-type lineage [57,77,112,119–121].”
From Novel activities of CYP11A1 and their potential physiological significance (2015) · cites this paper as [77]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“but unlike 1α,25(OH)2D3 and 25(OH)D3, pharmacological doses do not raise serum calcium in rodents [68–70].”
From The serum vitamin D metabolome: what we know and what is still to discover (2019) · cites this paper as [69]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Finally, CYP11A1-derived secosteroidal hydroxy-derivatives and Δ7steroids are biologically active when administered in vitro in a manner dependent on the structure of the compound and the lineage of the target cells, suggesting physiological roles for these metabolites.”
From Novel activities of CYP11A1 and their potential physiological significance (2015) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“These novel secosteroids lacking the C1α-hydroxyl group are noncalcemic, while 1α,20S(OH)2D3 displays low calcemic activity [68–70, 175].”
From The serum vitamin D metabolome: what we know and what is still to discover (2019) · cites this paper as [69]
In the citing paper
“20(OH)D3 at a doses as high as 3.0 μg/kg had no calcemic activity in rats whereas 1,25(OH)2D3 at the same dose raised calcium to 16.0 ± 1.2 mg/dL [84].”
From The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions (2014) · cites this paper as [84]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Self-citationHolick, M. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1678s · Cited by 3,198
Self-citationOverview of general physiologic features and functions of vitamin D
DeLuca, H. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1689s · Cited by 2,327
Vitamin D: a millenium perspective
Holick, M. F. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10338 · Cited by 1,319 · cited 2×
“This is consistent with a fundamental role of the hydroxyl group at the 1 alpha-position of vitamin D for the regulation of serum calcium levels [8,21].”
BackgroundSelf-citationNoncalcemic Actions of Vitamin D Receptor Ligands
Nagpal, S., Na, S., & Rathnachalam, R. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0002 · Cited by 961
Gallagher, R., Collins, S., Trujillo, J., McCredie, K., Ahearn, M., Tsai, S., Metzgar, R., Aulakh, G., Ting, R., Ruscetti, F., et al. (1979) · Blood · doi:10.1182/blood.v54.3.713.713 · Cited by 925
The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand
Rochel, N., Wurtz, J. M., Mitschler, A., Klaholz, B., & Moras, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80413-x · Cited by 842 · cited 1×
“Molecular modeling studies To understand the potential binding mode of 20S(OH)D3 in VDR, we selected the crystal structure of the VDR complex with calcitriol (PDB code: 1DB1)[35]and performed molecular modeling studies using Schrodinger Suite 2009 (Schrodinger Inc.”
MethodThiboutot, D., Gilliland, K., Cong, Z., Jabara, S., McAllister, J. M., Sivarajah, A., & Clawson, G. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12244.x · Cited by 301 · cited 1×
“Interestingly the number of tissues in which expression of P450scc has been identified is growing and includes bone, thymus, skin and brain as examples [30,39–44], raising the possibility of local production of the ligands identified in this study in the bone marrow environment.”
Background1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation.
Bikle, D. D., Nemanic, M. K., Gee, E., & Elias, P. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112609 · Cited by 269
Slominski, A., Zjawiony, J., Wortsman, J., Semak, I., Stewart, J., Pisarchik, A., Sweatman, T., Marcos, J., Dunbar, C., & C. Tuckey, R. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04356.x · Cited by 243 · cited 8×
“which can be further hydroxylated by classical steroidogenic enzymes to different steroidal 5,7-dienal hydroxy-products [29,30].”
BackgroundMethodSelf-citation
Cited by
Vitamin D metabolism, mechanism of action, and clinical applications
Bikle, D. D. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.12.016 · Cited by 1,933
Slominski (2012) · doi:10.1007/978-3-642-19683-6_1 · Cited by 461
Key role of CRF in the skin stress response system
Slominski, A. T., Zmijewski, M. A., Zbytek, B., Tobin, D. J., Theoharides, T. C., & Rivier, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1092 · Cited by 400
Self-citationNovel activities of CYP11A1 and their potential physiological significance
Slominski, A. T., Li, W., Kim, T.-K., Semak, I., Wang, J., Zjawiony, J. K., & Tuckey, R. C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.010 · Cited by 292
“Pregnalumisterol and some synthetic hydroxylumisterol 3 derivatives exhibit biological activity [76,77] further suggesting that metabolism of lumisterol by CYP11A1 in the skin may produce metabolites with physiological activity.”
Self-citationCytochromes P450 are essential players in the vitamin D signaling system
Schuster, I. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.06.022 · Cited by 284
Cutaneous hypothalamic–pituitary–adrenal axis homolog: regulation by ultraviolet radiation
Skobowiat, C., Dowdy, J. C., Sayre, R. M., Tuckey, R. C., & Slominski, A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00217.2011 · Cited by 269
Self-citationSlominski, A. T., Kim, T., Takeda, Y., Janjetovic, Z., Brożyna, A. A., Skobowiat, C., Wang, J., Postlethwaite, A., Li, W., Tuckey, R. C., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-242040 · Cited by 269
Self-citationSlominski, A. T., Kim, T., Shehabi, H. Z., Semak, I., Tang, E. K. Y., Nguyen, M. N., Benson, H. A. E., Korik, E., Janjetovic, Z., Chen, J., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-208975 · Cited by 266
“Moreover, 20(OH)D3 and 20(OH)D2 are nontoxic in rodents at doses as high as 30 g/kg, which defines them as potential therapeutic agents for hyperproliferative, fibrosing, or inflammatory disorders, or as adjuvants in cancer therapy (17, 19, 23).”
BackgroundSelf-citationThe serum vitamin D metabolome: what we know and what is still to discover
Tuckey, R. C., Cheng, C. Y. S., & Slominski, A. T. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.09.003 · Cited by 245
Self-citationSlominski, A. T., Kim, T.-K., Li, W., Postlethwaite, A., Tieu, E. W., Tang, E. K. Y., & Tuckey, R. C. (2015) · Scientific Reports · doi:10.1038/srep14875 · Cited by 229
Self-citationOn the role of skin in the regulation of local and systemic steroidogenic activities
Slominski, A. T., Manna, P. R., & Tuckey, R. C. (2015) · Steroids · doi:10.1016/j.steroids.2015.04.006 · Cited by 183
Self-citationSlominski, A. T., Kim, T.-K., Li, W., Yi, A.-K., Postlethwaite, A., & Tuckey, R. C. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.10.012 · Cited by 170
Self-citationVitamin D receptor(s): In the nucleus but also at membranes?
Zmijewski, M. A., & Carlberg, C. (2020) · Experimental Dermatology · doi:10.1111/exd.14147 · Cited by 162
Self-citationPhotoprotective Properties of Vitamin D and Lumisterol Hydroxyderivatives
Slominski, A. T., Chaiprasongsuk, A., Janjetović, Z., Kim, T., Stefan, J., Slominski, R. M., Hanumanthu, V. S., Raman, C., Qayyum, S., Song, Y., et al. (2020) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-020-00913-6 · Cited by 155
Self-citationSlominski, A. T., Kim, T.-K., Hobrath, J. V., Oak, A. S. W., Tang, E. K. Y., Tieu, E. W., Li, W., Tuckey, R. C., & Jetten, A. M. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.09.024 · Cited by 143
Self-citationSlominski, A. T., Brożyna, A. A., Zmijewski, M. A., Jóźwicki, W., Jetten, A. M., Mason, R. S., Tuckey, R. C., & Elmets, C. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.3 · Cited by 136
Self-citationThe Impact of Vitamin D on Skin Aging
Bocheva, G., Slominski, R. M., & Slominski, A. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169097 · Cited by 121
Self-citationSlominski, A. T., Kim, T.-K., Janjetovic, Z., Brożyna, A. A., Żmijewski, M. A., Xu, H., Sutter, T. R., Tuckey, R. C., Jetten, A. M., & Crossman, D. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103072 · Cited by 121
Self-citationExpression of vitamin D receptor decreases during progression of pigmented skin lesions
Brożyna, A. A., Jozwicki, W., Janjetovic, Z., & Slominski, A. T. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.09.014 · Cited by 120
Self-citationThe role of UV radiation and vitamin D in the seasonality and outcomes of infectious disease
Abhimanyu, A., & Coussens, A. K. (2017) · Photochemical & Photobiological Sciences · doi:10.1039/c6pp00355a · Cited by 117
Biological Effects of CYP11A1-Derived Vitamin D and Lumisterol Metabolites in the Skin
Slominski, A. T., Kim, T., Janjetović, Z., Slominski, R. M., Li, W., Jetten, A. M., Indra, A. K., Mason, R. S., & Tuckey, R. C. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.04.022 · Cited by 116
Self-citationSlominski, A. T., Kim, T.-K., Janjetovic, Z., Tuckey, R. C., Bieniek, R., Yue, J., Li, W., Chen, J., Nguyen, M. N., Tang, E. K. Y., et al. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00203.2010 · Cited by 113
“The calcemic effects of 20(OH)D2 were compared with those of 1,25(OH)2D3 as described previously for 1,20(OH)2D3 and 20(OH)D3, with some modifications (61).”
BackgroundMethodResultSelf-citationNongenomic Activities of Vitamin D
Zmijewski, M. A. (2022) · Nutrients · doi:10.3390/nu14235104 · Cited by 108
Self-citationThe significance of CYP11A1 expression in skin physiology and pathology
Slominski, R. M., Raman, C., Elmets, C. A., Jetten, A. M., Slominski, A. T., & Tuckey, R. C. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111238 · Cited by 106
Self-citationOn the role of classical and novel forms of vitamin D in melanoma progression and management
Slominski, A. T., Brożyna, A. A., Skobowiat, C., Zmijewski, M. A., Kim, T., Janjetović, Z., Oak, A. S. W., Jóźwicki, W., Jetten, A. M., Mason, R. S., et al. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.06.013 · Cited by 105
Self-citationSlominski, A. T., Kim, T.-K., Shehabi, H. Z., Tang, E. K. Y., Benson, H. A. E., Semak, I., Lin, Z., Yates, C. R., Wang, J., Li, W., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.12.012 · Cited by 100
“These novel vitamin D3 hydroxy-derivatives are biologically active with a potency defined by the cell lineage (Slominski et al., 2010, 2013c), and are at least as potent as the classical 1,25(OH)2D3 (calcitriol) in skin cells with anti-proliferative, pro-differentiation, anti-cancer and…”
Self-citationVitamin D Signaling in Psoriasis: Pathogenesis and Therapy
Brożyna, A. A., Slominski, R. M., Nedoszytko, B., Zmijewski, M. A., & Slominski, A. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158575 · Cited by 100
Self-citationVitamin D in Neurological Diseases
Plantone, D., Primiano, G., Manco, C., Locci, S., Servidei, S., & Stefano, N. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010087 · Cited by 93
Slominski, A. T., Janjetović, Z., Kim, T., Wright, A. C., Grese, L., Riney, S. J., Nguyen, M. N., & Tuckey, R. C. (2012) · UWA Profiles and Research Repository (UWA) · Cited by 93
Self-citationJanjetovic, Z., Brozyna, A. A., Tuckey, R. C., Kim, T.-K., Nguyen, M. N., Jozwicki, W., Pfeffer, S. R., Pfeffer, L. M., & Slominski, A. T. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.458 · Cited by 91
“…a product of cytochrome P450scc action (Slominski et al, 2005), affects the proliferation and differentiation of human keratinocytes (Zbytek et al, 2008) and leukaemic cells (Slominski et al, 2010), but also inhibits nuclear factor-kB (NFkB) activity in keratinocytes (Janjetovic et al, 2009).”
BackgroundSelf-citationCytochromes P450 and Skin Cancer: Role of Local Endocrine Pathways
Slominski, A., Zmijewski, M., Semak, I., Zbytek, B., Pisarchik, A., Li, W., Zjawiony, J., & Tuckey, R. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113139990308 · Cited by 91
Self-citationBrożyna, A. A., Jóźwicki, W., & Slominski, A. T. (2014) · PubMed · Cited by 92
Self-citationEndogenous Photosensitizers in Human Skin
Bastos, E. L., Quina, F. H., & Baptista, M. S. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00787 · Cited by 91
Slominski, A., Janjetovic, Z., Tuckey, R. C., Nguyen, M. N., Bhattacharya, K. G., Wang, J., Li, W., Jiao, Y., Gu, W., Brown, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3074 · Cited by 89
Self-citationTuckey, R. C., Li, W., Shehabi, H. Z., Janjetovic, Z., Nguyen, M. N., Kim, T.-K., Chen, J., Howell, D. E., Benson, H. A. E., Sweatman, T., et al. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040071 · Cited by 88
“We have previously found that the second major product of P450scc action on vitamin D3, 20,23(OH)2D3, shares the potency and many of the effects of 20(OH)D3 on skin and leukemia cells, although some variations between these analogs were seen, depending on the parameter measured and the cell type used (Janjetovic et al…”
InfluentialSelf-citationMalignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling
Slominski, R. M., Kim, T., Janjetović, Z., Brożyna, A. A., Podgórska, E., Dixon, K. M., Mason, R. S., Tuckey, R. C., Sharma, R., Crossman, D. K., et al. (2024) · Cancers · doi:10.3390/cancers16122262 · Cited by 86
Self-citationSlominski, A. T., Kim, T.-K., Hobrath, J. V., Janjetovic, Z., Oak, A. S. W., Postlethwaite, A., Lin, Z., Li, W., Takeda, Y., Jetten, A. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10202-7 · Cited by 82
Self-citationSlominski, A. T., Kim, T.-K., Chen, J., Nguyen, M. N., Li, W., Yates, C. R., Sweatman, T., Janjetovic, Z., & Tuckey, R. C. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.07.027 · Cited by 81
“7DHP, its hydroxy-derivatives and 20(OH)7DHC are biologically active towards skin and leukemia cells (Slominski et al., 2009, Slominski et al., 2010), and as indicated by the pathological features of SLOS patients (Nowaczyk and Waye, 2001, Marcos et al., 2004, Tint et al., 1994, Smith et al., 1964).”
Self-citationA Dermatologist's Perspective on Vitamin D
Vanchinathan, V., & Lim, H. W. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.12.010 · Cited by 81
Wang, J., Slominski, A. T., Tuckey, R. C., Janjetović, Z., Kulkarni, A. L., Chen, J., Postlethwaite, A. E., Miller, D. D., & Li, W. (2012) · UWA Profiles and Research Repository (UWA) · Cited by 83
Self-citationSlominski, A. T., Janjetovic, Z., Kim, T.-K., Wasilewski, P., Rosas, S., Hanna, S., Sayre, R. M., Dowdy, J. C., Li, W., & Tuckey, R. C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.01.014 · Cited by 77
Self-citationZhang, Z., He, J., Fu, W., Zhang, C., & Zhang, Z. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1926 · Cited by 77
Novel vitamin D photoproducts and their precursors in the skin
Slominski, A., Kim, T.-K., Zmijewski, M. A., Janjetovic, Z., Li, W., Chen, J., Kusniatsova, E. I., Semak, I., Postlethwaite, A., Miller, D. D., et al. (2013) · Dermato-Endocrinology · doi:10.4161/derm.23938 · Cited by 76
Self-citationRelevance of Vitamin D in Melanoma Development, Progression and Therapy
Brożyna, A. A., Hoffman, R. M., & Slominski, A. T. (2019) · Anticancer Research · doi:10.21873/anticanres.13976 · Cited by 72
Self-citationNeuroendocrinology of the skin: An overview and selective analysis
Zmijewski, M. A., & Slominski, A. T. (2011) · Dermato-Endocrinology · doi:10.4161/derm.3.1.14617 · Cited by 71
Self-citationBrożyna, A. A., Jóźwicki, W., Janjetovic, Z., & Slominski, A. T. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.03.031 · Cited by 70
Self-citationChemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity
Li, W., Chen, J., Janjetovic, Z., Kim, T.-K., Sweatman, T., Lu, Y., Zjawiony, J., Tuckey, R. C., Miller, D., & Slominski, A. (2010) · Steroids · doi:10.1016/j.steroids.2010.05.021 · Cited by 68
Self-citationNon-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System
Zhang, S., Miller, D. D., & Li, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042128 · Cited by 68
Self-citationKim, T.-K., Wang, J., Janjetovic, Z., Chen, J., Tuckey, R. C., Nguyen, M. N., Tang, E. K. Y., Miller, D., Li, W., & Slominski, A. T. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.001 · Cited by 67
Self-citationCOVID‐19 and Vitamin D: A lesson from the skin
Slominski, R. M., Stefan, J., Athar, M., Holick, M. F., Jetten, A. M., Raman, C., & Slominski, A. T. (2020) · Experimental Dermatology · doi:10.1111/exd.14170 · Cited by 66
Self-citationWierzbicka, J., Piotrowska, A., & Zmijewski, M. A. (2014) · Acta Biochimica Polonica · doi:10.18388/abp.2014_1830 · Cited by 65
Self-citationCYP11A1 in skin: an alternative route to photoprotection by vitamin D compounds
Tongkao-on, W., Carter, S., Reeve, V. E., Dixon, K. M., Gordon-Thomson, C., Halliday, G. M., Tuckey, R. C., & Mason, R. S. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.015 · Cited by 63
Self-citationSlominski, A. T., Kim, T., Slominski, R. M., Song, Y., Janjetović, Z., Podgórska, E., Reddy, S. B., Song, Y., Raman, C., Tang, E. K. Y., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200578r · Cited by 62
Self-citationChen, J., Wang, J., Kim, T., Tieu, E. W., Tang, E. K. Y., Lin, Z., Kovacic, D., Miller, D. D., Postlethwaite, A. E., Tuckey, R. C., et al. (2014) · UWA Profiles and Research Repository (University of Western Australia) · Cited by 65
Self-citationRegulation of Hepatic Cytochromes P450 by Lipids and Cholesterol
Hafner, M., Režen, T., & Rozman, D. (2011) · Current Drug Metabolism · doi:10.2174/138920011795016890 · Cited by 59
Activity of 25-Hydroxylase in Human Gingival Fibroblasts and Periodontal Ligament Cells
Liu, K., Meng, H., & Hou, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052053 · Cited by 57
Slominski, A. T., Brożyna, A. A., Zmijewski, M. A., Janjetović, Z., Kim, T., Slominski, R. M., Tuckey, R. C., Mason, R. S., Jetten, A. M., Guroji, P., et al. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-46227-7_13 · Cited by 57
Self-citationTieu, E. W., Li, W., Chen, J., Baldisseri, D. M., Slominski, A. T., & Tuckey, R. C. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.11.012 · Cited by 56
Self-citationDifferentiation Therapy of Acute Myeloid Leukemia
Gocek, E., & Marcinkowska, E. (2011) · Cancers · doi:10.3390/cancers3022402 · Cited by 56
Vitamin D analogs 17, 20S(OH)2pD and 17,20R(OH)2pD are noncalcemic and exhibit antifibrotic activity
Slominski, A. T., Li, W., Bhattacharya, S. K., Smith, R. A., Johnson, P. L., Chen, J., Nelson, K. E., Tuckey, R. C., Miller, D., Jiao, Y., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.425 · Cited by 51
“Thus, 17,20R(OH)2pD and 17,20R(OH)2pD show the same noncalcemic properties as the structurally similar 20(OH)pD (Holick et al., 1975) and 20(OH)D3 (Slominski et al., 2010).”
InfluentialSelf-citationZmijewski, M. A., Li, W., Chen, J., Kim, T.-K., Zjawiony, J. K., Sweatman, T. W., Miller, D. D., & Slominski, A. T. (2011) · Steroids · doi:10.1016/j.steroids.2010.10.009 · Cited by 51
“Our focus has been on analogs of vitamin D3 without the cholesteroltype side-chain with potentially low calcemic activity [18,19,30–32,38].”
Self-citationDifferential antitumor effects of vitamin D analogues on colorectal carcinoma in culture
WIERZBICKA, J. M., BINEK, A., AHRENDS, T., KA, J. D. N., SZYDŁOWSKA, A., TURCZYK, Ł., WĄSIEWICZ, T., WIERZBICKI, P. M., SĄDEJ, R., TUCKEY, R. C., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3088 · Cited by 51
Self-citationChaiprasongsuk, A., Janjetović, Z., Kim, T., Tuckey, R. C., Li, W., Raman, C., Panich, U., & Slominski, A. T. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.05.016 · Cited by 49
Self-citationBerretta, M., Quagliariello, V., Bignucolo, A., Facchini, S., Maurea, N., Francia, R. D., Fiorica, F., Sharifi, S., Bressan, S., Richter, S. N., et al. (2022) · Antioxidants · doi:10.3390/antiox11061090 · Cited by 50
Vitamin D derivatives enhance cytotoxic effects of H2O2 or cisplatin on human keratinocytes
Piotrowska, A., Wierzbicka, J., Ślebioda, T., Woźniak, M., Tuckey, R. C., Slominski, A. T., & Żmijewski, M. A. (2016) · Steroids · doi:10.1016/j.steroids.2016.04.002 · Cited by 48
Self-citationWasiewicz, T., Szyszka, P., Cichorek, M., Janjetovic, Z., Tuckey, R., Slominski, A., & Zmijewski, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16046645 · Cited by 48
Self-citationLin, Z., Marepally, S. R., Goh, E. S. Y., Cheng, C. Y. S., Janjetović, Z., Kim, T., Miller, D. D., Postlethwaite, A. E., Slominski, A. T., Tuckey, R. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19183-7 · Cited by 50
Self-citationNew vitamin D analogs as potential therapeutics in melanoma
Szyszka, P., Zmijewski, M. A., & Slominski, A. T. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.40 · Cited by 45
Self-citationNoncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo models
Skobowiat, C., Oak, A. S. W., Kim, T.-K., Yang, C. H., Pfeffer, L. M., Tuckey, R. C., & Slominski, A. T. (2017) · Oncotarget · doi:10.18632/oncotarget.14193 · Cited by 44
“These hydroxyderivatives display antitumorigenic and anti-melanoma activities comparable to those of 1,25(OH)2D3 [47–52], and are noncalcemic in rodents at therapeutic doses as high as 60 μg/kg [50, 53, 54].”
BackgroundSelf-citationTieu, E. W., Tang, E. K. Y., Chen, J., Li, W., Nguyen, M. N., Janjetovic, Z., Slominski, A., & Tuckey, R. C. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.09.032 · Cited by 44
Self-citationLumisterol is metabolized by CYP11A1: discovery of a new pathway
Tuckey, R. C., Slominski, A. T., Cheng, C. Y. S., Chen, J., Kim, T.-K., Xiao, M., & Li, W. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.08.004 · Cited by 43
“…a range of cell types cultured in vitro (reviewed in (Slominski et al., 2014a)), and in reducing inflammation and skin fibrosis in mice in vivo (Slominski et al., 2013, 2014a), but lack the toxic and calcemic effects seen with high doses of 1,25(OH)2D3 (Slominski et al., 2010; Wang et al., 2012).”
BackgroundSelf-citationAkter, R., Afrose, A., Sharmin, S., Rezwan, R., Rahman, M. R., & Neelotpol, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113285 · Cited by 43
Hydroxylation of CYP11A1-derived products of vitamin D3 metabolism by human and mouse CYP27B1
Tang, E. K. Y., Chen, J., Janjetovic, Z., Tieu, E. W., Slominski, A. T., Li, W., & Tuckey, R. C. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.050955 · Cited by 42
“…and display antiinflammatory activity by decreasing nuclear factor-ĸB activity (Zbytek et al., 2008; Janjetovic et al., 2009, 2010, 2011; Li et al., 2010; Slominski et al., 2010, 2011, 2012a; Tang et al., 2010a; Tuckey et al., 2011; Kim et al., 2012; Lu et al., 2012; Wang et al., 2012).”
BackgroundSelf-citationTuckey, R. C., Li, W., Ma, D., Cheng, C. Y. S., Wang, K., Kim, T., Jeayeng, S., & Slominski, A. T. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.02.008 · Cited by 42
Self-citationPiotrowska, A., Wierzbicka, J., Rybarczyk, A., Tuckey, R. C., Slominski, A. T., & Zmijewski, M. A. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4725 · Cited by 41
Self-citationSlominski, A. T., Brożyna, A. A., Kim, T., Elsayed, M., Janjetović, Z., Qayyum, S., Slominski, R. M., Oak, A. S. W., Li, C., Podgórska, E., et al. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5386 · Cited by 41
Self-citationBurns, E. M., Elmets, C. A., & Yusuf, N. (2014) · Photochemistry and Photobiology · doi:10.1111/php.12382 · Cited by 42
Tang, E. K. Y., Li, W., Janjetovic, Z., Nguyen, M. N., Wang, Z., Slominski, A., & Tuckey, R. C. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.034389 · Cited by 40
“…the properties of 1,25(OH)2D3 such as the inhibition of proliferation, the promotion of differentiation, and suppression of inflammation, despite lacking the 1 -hydroxyl group usually seen in vitamin D receptor agonists (Zbytek et al., 2008; Janjetovic et al., 2009, 2010; Slominski et al., 2010).”
BackgroundInfluentialSelf-citationVitamin D3 and Ischemic Stroke: A Narrative Review
Lasoń, W., Jantas, D., Leśkiewicz, M., Regulska, M., & Basta‐Kaim, A. (2022) · Antioxidants · doi:10.3390/antiox11112120 · Cited by 40
Tang, E. K. Y., Voo, K. J. Q., Nguyen, M. N., & Tuckey, R. C. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.022 · Cited by 40
Self-citationBikle, D. D. (2018) · Frontiers of hormone research · doi:10.1159/000486062 · Cited by 37
Gezen‐Ak, D., & Dursun, E. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230214 · Cited by 36
Human cytochrome P450scc (CYP11A1) catalyzes epoxide formation with ergosterol
Tuckey, R. C., Nguyen, M. N., Chen, J., Slominski, A. T., Baldisseri, D. M., Tieu, E. W., Zjawiony, J. K., & Li, W. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042515 · Cited by 32
Self-citationZabul, P., Woźniak, M., Slominski, A. T., Preis, K., Górska‐Ponikowska, M., Korożan, M., Wieruszewski, J., Zmijewski, M. A., Zabul, E., Tuckey, R. C., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160613043 · Cited by 32
Self-citationLin, Z., Chen, H., Belorusova, A. Y., Bollinger, J. C., Tang, E. K. Y., Janjetović, Z., Kim, T., Wu, Z., Miller, D. D., Slominski, A. T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10917-7 · Cited by 33
Self-citationNakashyan, V., Tipton, D. A., Karydis, A., Livada, R., & Stein, S. H. (2017) · Journal of Periodontal Research · doi:10.1111/jre.12452 · Cited by 31
Shin, M. H., Lee, Y., Kim, M. K., Lee, D. H., & Chung, J. H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105449 · Cited by 32
Wang, L., Wang, C., Wang, J., Huang, X., & Cheng, Y. (2016) · Scientific Reports · doi:10.1038/srep38962 · Cited by 30
Maj, E., Filip‐Psurska, B., Świtalska, M., Kutner, A., & Wietrzyk, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126016 · Cited by 29
Podgórska, E., Kim, T., Janjetović, Z., Urbańska, K., Tuckey, R. C., Bae, S., & Slominski, A. T. (2021) · Cancers · doi:10.3390/cancers13133111 · Cited by 30
Self-citationDesign, Synthesis, and Biological Action of 20 R-Hydroxyvitamin D3
Lu, Y., Chen, J., Janjetovic, Z., Michaels, P., Tang, E. K. Y., Wang, J., Tuckey, R. C., Slominski, A. T., Li, W., & Miller, D. D. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201478e · Cited by 28
Self-citationCytochrome P450 Vitamin D Hydroxylases in Inflammation and Cancer
Gröschel, C., Tennakoon, S., & Kállay, E. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2015.03.002 · Cited by 28
Novel CYP11A1-Derived Vitamin D and Lumisterol Biometabolites for the Management of COVID-19
Qayyum, S., Slominski, R. M., Raman, C., & Slominski, A. T. (2022) · Nutrients · doi:10.3390/nu14224779 · Cited by 27
Self-citationAntifibrogenic Activities of CYP11A1-derived Vitamin D3-hydroxyderivatives Are Dependent on RORγ
Janjetović, Z., Postlethwaite, A. E., Kang, H. S., Kim, T., Tuckey, R. C., Crossman, D. K., Qayyum, S., Jetten, A. M., & Slominski, A. T. (2020) · Endocrinology · doi:10.1210/endocr/bqaa198 · Cited by 27
Self-citationVitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study
Song, Y., Qayyum, S., Greer, R. A., Slominski, R. M., Raman, C., Slominski, A. T., & Song, Y. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1964601 · Cited by 26
Self-citationWei, Y., Zheng, W., Li, B., Tong, Q., Shi, H., & Li, X. (2019) · Animals · doi:10.3390/ani10010015 · Cited by 26
Oak, A. S. W., Bocheva, G., Kim, T., Brożyna, A. A., Janjetović, Z., Athar, M., Tuckey, R. C., & Slominski, A. T. (2020) · Anticancer Research · doi:10.21873/anticanres.14216 · Cited by 26
Self-citationAlternative pathways for vitamin D metabolism
Slominski, A. T., Tuckey, R. C., Jenkinson, C., Li, W., & Jetten, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91386-7.00001-5 · Cited by 25
Self-citationLin, Z., Marepally, S. R., Ma, D., Myers, L. K., Postlethwaite, A. E., Tuckey, R. C., Cheng, C. Y. S., Kim, T., Yue, J., Slominski, A. T., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00881 · Cited by 26
Self-citationPostlethwaite, A. E., Tuckey, R. C., Kim, T., Li, W., Bhattacharya, S. K., Myers, L. K., Brand, D. D., & Slominski, A. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678487 · Cited by 25
Self-citation
Metadata
- Authors
- Slominski, A. T., Janjetovic, Z., Fuller, B. E., Zmijewski, M. A., Tuckey, R. C., Nguyen, M. N., Sweatman, T., Li, W., Zjawiony, J., Miller, D., Chen, T. C., Lozanski, G., & Holick, M. F.
- Affiliations
- University of Tennessee Health Science Center (US)
- Gdańsk Medical University (PL)
- The University of Western Australia (AU)
- University of Mississippi (US)
- Boston University (US)
- The Ohio State University (US)
- Corresponding author
- Slominski, Andrzej T.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-03-26
- Volume
- 5
- Issue
- 3
- Pages
- e9907
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2845617
- OpenAlex
- W2020048876
- Cited by
- 149
- References
- 54
- Citations by year
- 2025: 3 · 2024: 9 · 2023: 7 · 2022: 13 · 2021: 12 · 2020: 11 · 2019: 4 · 2018: 11 · 2017: 9 · 2016: 9 · 2015: 12 · 2014: 12 · 2013: 7 · 2012: 13
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- OpenBU (Boston University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- U.S. Public Health Service (R01A052190)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK040561)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052190)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
- Keywords
- vitamin D3 metabolism, 7-dehydrocholesterol, cytochrome P450scc, secosteroids, lumisterol, leukemia cell differentiation, leukemia cell proliferation, calcemic activity, chronic myeloid leukemia, promyelocytic leukemia
- MeSH terms
- Animals, Antineoplastic Agents, Calcifediol, Cholecalciferol, Cholesterol Side-Chain Cleavage Enzyme, Dehydrocholesterols, Humans, Hypercalcemia, Pregnenolone, Gene Expression Regulation, Leukemic, HL-60 Cells, U937 Cells, Cell Line, Tumor, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.